Being infected with herpes simplex virus type 1 is associated with a 48% increase in the risk of Alzheimer’s disease or other types of dementia, according to a meta-analysis published in Open Forum Infectious Diseases.
About two-thirds of people worldwide under the age of 50 carry HSV-1, a pathogen best known for causing cold sores and genital blisters. Beyond these visible symptoms, the virus can invade the central nervous system and remain latent for decades. Earlier laboratory work using neural stem cells demonstrated that HSV-1 triggers cellular changes resembling those seen in Alzheimer’s pathology.
Researchers at the University of Southern California Keck School of Medicine led the systematic review, sifting through 2,178 international papers before selecting 11 studies for their final analysis. The elevated risk held steady even after investigators controlled for variables such as age and heart disease status.
The findings come as researchers continue to debate whether infections can trigger cognitive decline. Past clinical studies on herpes infections and dementia produced mixed results — one earlier review found no increased risk — but this meta-analysis shows a consistent link across several analytical models.
With no current cure for HSV-1, clinicians rely on antiviral drugs to suppress outbreaks and limit transmission. Scientists are testing those same medications in randomized controlled trials to see if they alter the course of Alzheimer’s disease. At the same time, public health data links multiple routine adult immunizations to lower rates of neurodegeneration.
Large observational studies indicate that routine vaccinations can reduce dementia risk by 25% to 40%. The strongest protective signals emerge from inoculations targeting influenza, respiratory syncytial virus, pneumococcal disease, diphtheria, tetanus, pertussis, and shingles.
An estimated 7.4 million Americans currently live with Alzheimer’s disease. Demographic projections indicate that figure will nearly double by the year 2060, intensifying urgency across the scientific community to identify modifiable risk factors.
Founded in 1885, the Keck School of Medicine of USC is the oldest medical school in Southern California. It was among the first medical schools to adopt “Introduction to Clinical Medicine” courses, giving first-year students real-world patient care experience. In 1970, the school led the movement toward using standardized patients for medical training, a model later adopted nationwide.
Researchers have tied 22 distinct viral infections to forms of dementia in recent years. Clinical trials are now testing whether targeting these pathogens can change neurological outcomes, while preventive measures and antiviral strategies stay central to research on preserving cognitive function.